Current status and breakthroughs in treating advanced non-small cell lung cancer with EGFR exon 20 insertion mutations
Recently, targeted therapy and immunotherapy have emerged as effective treatment options for non-small cell lung cancer (NSCLC). This progress has been facilitated by the rapid development of diagnostic and therapeutic technologies and the continuous r…